Analyst Ratings for Teva Pharma (TEVA) [Sells]

TEVA Rating Summary

TEVA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TEVA
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $54.30 (+8.9%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/30/2013 Goldman Sachs
» Updated 10/30/2013
Downgrade Sell
(Neutral)
40.00
(N/A)
39.90 49.84 24.91% Details
Like TEVA Ratings? Also take a look at MYL, PFE, MNTA, PATH

TEVA Ratings News